These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32304089)

  • 1. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
    Kong FE; Tang YQ; Gong YF; Mo JQ; Zhao Y; Li MM; Cheng W; Li HL; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
    Hepatol Int; 2020 Jul; 14(4):521-533. PubMed ID: 32304089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
    Li MM; Tang YQ; Gong YF; Cheng W; Li HL; Kong FE; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
    BMC Cancer; 2019 Aug; 19(1):851. PubMed ID: 31462277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
    Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
    Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
    Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
    Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
    BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.
    Coulouarn C; Factor VM; Thorgeirsson SS
    Hepatology; 2008 Jun; 47(6):2059-67. PubMed ID: 18506891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
    Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
    J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.
    Ono Y; Hiratsuka Y; Murata M; Takasawa A; Fukuda R; Nojima M; Tanaka S; Osanai M; Hirata K; Sawada N
    Virchows Arch; 2016 Oct; 469(4):417-26. PubMed ID: 27444172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma.
    Li B; Feng W; Luo O; Xu T; Cao Y; Wu H; Yu D; Ding Y
    Sci Rep; 2017 Jul; 7(1):5517. PubMed ID: 28717245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.